Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Possis Medical

This article was originally published in The Gray Sheet

Executive Summary

Raises $6 mil. in private placement financing to expand marketing of the AngioJet thrombectomy system for coronary arteries following FDA approval in March. Possis clarifies that while use of the system requires placement of a temporary pacing catheter, "this is not unusual in cardiovascular devices," as was implied by "The Gray Sheet" (March 22, p. 17). A price comparison with Boston Scientific's $600 Oasis thrombectomy catheter (March 22, p. 16) should have noted that the AngioJet model comparable to Oasis also is $600. Both products require purchase of a separate drive unit
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT011769

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel